Tennessee Senate Bill SB0056

Tennessee 2025-2026 Regular Session

• Introduced: 1/9/25
• Chaptered: 3/24/25
• Passed: 3/24/25

Caption

AN ACT to amend Tennessee Code Annotated, Title 4, Chapter 29 and Title 63, Chapter 10, relative to the board of pharmacy.

Summary

This bill makes a narrow change to Tennessee law governing the Board of Pharmacy. It removes the Board of Pharmacy from the list of state boards and commissions that are subject to automatic repeal under Tennessee Code Annotated, Title 4, Chapter 29, and instead adds the board to the list of entities that are expressly continued in law. In practical terms, the bill preserves the board’s existence and avoids its scheduled sunset review or expiration. The measure is administrative rather than substantive: it does not change pharmacy licensing standards, disciplinary authority, or the board’s regulatory powers. Instead, it updates the state’s statutory framework so the Board of Pharmacy remains a continuing governmental body under Title 63, Chapter 10. The bill took effect immediately upon becoming law.

Impact

The bill amends Tennessee Code Annotated §§ 4-29-246 and 4-29-250 to remove the Board of Pharmacy from the automatic termination list and place it on the list of boards continued by statute. This preserves the board’s legal authority and ongoing operation, affecting the state agency responsible for regulating pharmacists, pharmacies, and related professional licensing matters.

Sentiment

The available legislative history shows little to no controversy. The Senate Government Operations Committee recommended passage unanimously, with 8 yeas and 0 nays, suggesting broad support for keeping the Board of Pharmacy in place. No committee transcript is available, and the bill’s text indicates a routine continuation measure rather than a policy dispute.

Contention

There is no recorded substantive opposition in the provided materials. Any potential point of discussion would likely have been procedural rather than ideological: whether the Board of Pharmacy should remain subject to sunset review or be permanently continued. The committee vote suggests no meaningful disagreement among members on that issue.